ArticleRSC advances2020

Cancer cell membrane-camouflaged MOF nanoparticles for a potent dihydroartemisinin-based hepatocellular carcinoma therapy.

Yusha Xiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.